Serveur d'exploration SRAS - Exploration (Accueil)

Index « AbsEn.i » - entrée « research »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
rescuing < research < researched  Facettes :

List of bibliographic references indexed by research

Number of relevant bibliographic references: 561.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000029 (2020) Yu-Shi Zhang [République populaire de Chine] ; Wei-Hong Cong [République populaire de Chine] ; Jing-Jing Zhang [République populaire de Chine] ; Fei-Fei Guo [République populaire de Chine] ; Hong-Mei Li [République populaire de Chine][Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
000030 (2020) Yeyan He [République populaire de Chine] ; Chanying Zheng [République populaire de Chine][Replication and transmission mechanisms of highly pathogenic human coronaviruses].
000032 (2020) Ming Niu [République populaire de Chine] ; Rui-Lin Wang [République populaire de Chine] ; Zhong-Xia Wang [République populaire de Chine] ; Ping Zhang [République populaire de Chine] ; Zhao-Fang Bai [République populaire de Chine] ; Jing Jing [République populaire de Chine] ; Yu-Ming Guo [République populaire de Chine] ; Xu Zhao [République populaire de Chine] ; Xiao-Yan Zhan [République populaire de Chine] ; Zi-Teng Zhang [République populaire de Chine] ; Xue-Ai Song [République populaire de Chine] ; En-Qiang Qin [République populaire de Chine] ; Jia-Bo Wang [République populaire de Chine] ; Xiao-He Xiao [République populaire de Chine][Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].
000039 (2020) Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine][Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
000050 (2020) Cai-Xia Yan [République populaire de Chine] ; Jia Li [République populaire de Chine] ; Xin Shen [République populaire de Chine] ; Li Luo [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Ming-Yuan Li [République populaire de Chine][Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].
000055 (2020) J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine][Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures].
000057 (2020) H Y Tian [République populaire de Chine][2019-nCoV: new challenges from coronavirus].
000062 (2020) Binqing Fu [République populaire de Chine] ; Xiaoling Xu [République populaire de Chine] ; Haiming Wei [République populaire de Chine]Why tocilizumab could be an effective treatment for severe COVID-19?
000067 (2020) Mary A. Lake [Royaume-Uni]What we know so far: COVID-19 current clinical knowledge and research.
000077 (2020) Mahmoud Kandeel [Égypte] ; Mohammed Al-Nazawi [Arabie saoudite]Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.
000086 (2020) Yun-Yun Wang [République populaire de Chine] ; Ying-Hui Jin [République populaire de Chine] ; Xue-Qun Ren [République populaire de Chine] ; Yi-Rong Li [République populaire de Chine] ; Xiao-Chun Zhang [République populaire de Chine] ; Xian-Tao Zeng [République populaire de Chine] ; Xing-Huan Wang [République populaire de Chine]Updating the diagnostic criteria of COVID-19 "suspected case" and "confirmed case" is necessary.
000114 (2020) Yu Han [République populaire de Chine] ; Hailan Yang [République populaire de Chine]The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective.
000116 (2020) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
000121 (2020) Akram Aminjafari [Iran] ; Sorayya Ghasemi [Iran]The possible of immunotherapy for COVID-19: A systematic review.
000125 (2020) Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan YanThe origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
000139 (2020) Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine]The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
000149 (2020) Y J Duan [République populaire de Chine] ; Q. Liu [République populaire de Chine] ; S Q Zhao [République populaire de Chine] ; F. Huang [République populaire de Chine] ; L. Ren [République populaire de Chine] ; L. Liu [République populaire de Chine] ; Y W Zhou [République populaire de Chine]The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 (COVID-19) and Its Research Progress in Forensic Toxicology.
000158 (2020) Peter J. Hotez ; Maria Elena Bottazzi ; David B. CorryThe Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
000165 (2020) Shibo Jiang [République populaire de Chine, États-Unis] ; Zheng-Li Shi [République populaire de Chine]The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus
000179 (2020) Pranab Chatterjee [Inde] ; Nazia Nagi [Inde] ; Anup Agarwal [Inde] ; Bhabatosh Das [Inde] ; Sayantan Banerjee [Inde] ; Swarup Sarkar [Inde] ; Nivedita Gupta [Inde] ; Raman R. Gangakhedkar [Inde]The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence.
000207 (2020) Suhas Srinivasan [États-Unis] ; Hongzhu Cui [États-Unis] ; Ziyang Gao [États-Unis] ; Ming Liu [États-Unis] ; Senbao Lu [États-Unis] ; Winnie Mkandawire [États-Unis] ; Oleksandr Narykov [États-Unis] ; Mo Sun [États-Unis] ; Dmitry Korkin [États-Unis]Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "research" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "research" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    research
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021